Overview
Performance
Portfolio
ESG
Dividends
Charges
Gearing
Research
Announcements
Management
Documents
How to invest
Data as at: 19/05/2022
In
Objective
To provide Shareholders with capital growth and income over the long term, through investment in listed or quoted global healthcare companies.
AIC sector
Management group
Bellevue Asset Management
Company website
Launch date
02/12/2016
November
Domicile
United Kingdom
Fund manager
Paul Major, Brett Darke
Dividend frequency
Semi-Annually
Wind-up provisions
There are no specific provisions for the termination of the life of the Company.
Total assets (m) | Market Cap (m) | Price (last close) | NAV | Dividend dates | Discount / premium (%) | Gearing (%) | Dividend yield (%) | Ongoing charge (%) |
---|---|---|---|---|---|---|---|---|
991.67 | 880.76 | 151.00 | 149.45 | Feb, Jul | 1.04 | 11 | 4.28 | 1.08 (30/11/2021) |
Scroll
Dividends
Dividends declared in last 12 months
Ex-Dividend date | Payment date | Dividend amount | Dividend type | Special dividend | Financial year |
---|---|---|---|---|---|
17/03/2022 | 28/04/2022 | 3.015 | Capital | No | 2021 |
29/07/2021 | 03/09/2021 | 3.015 | Capital | No | 2021 |
Scroll
Performance (%)
Return type | 1 year | 3 years | 5 years | 10 years | |
---|---|---|---|---|---|
Bellevue Healthcare | Share price total return | -12.9 | 20.1 | 56.2 | N/A |
Biotechnology & Healthcare AIC sector | Share price total return | -15.8 | 2.2 | 30.8 | 298.2 |
Scroll
Share structure
Number of shares
583,282,380
Traded volumes (number of shares)
Yesterday | 1 month | 1 year | 5 years | |
---|---|---|---|---|
Total | 1,087,002 | 19,898,247 | 238,497,564 | 990,232,446 |
Average | N/A | 947,536 | 942,678 | 782,174 |
Scroll
Traded values (m)
Trading details
Top holdings
Data as at : 30/11/2021
Investment | % of total assets |
---|---|
Jazz Pharmaceuticals PLC | 7.6 |
Insmed Inc | 7.1 |
Anthem Inc | 5.9 |
Humana Inc | 5.5 |
Option Care Health Inc | 5.5 |
Sarepta Therapeutics Inc | 5.0 |
Tandem Diabetes Care Inc | 4.7 |
UnitedHealth Group Inc | 4.5 |
Bristol-Myers Squibb Co | 4.2 |
Amedisys Inc | 3.9 |
Data provided by Morningstar.
Company documents provided by FE fundinfo.